Thinq Pharma-Cro Limited - Company Profile

It is a pharma public limited company based in Mumbai, Maharashtra, India, established in 2006.
2006 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Thinq Pharma-Cro Limited

Thinq Pharma-Cro Limited, a active public limited company, was established on 10 November 2006 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24239MH2006PLC165473. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹0.50 M.

It upholds a compliant status. Employing 148 professional, Its leadership includes Chandrashekhar Shankar Nadkarni (Managing Director), Ravindra Ramakant Gulgule (Director), Rohit Ramakant Gulgule (Director). Past directors included Girish Suresh Virkar, Shibani Chandrashekhar Nadkarni. It holds ₹48.38 Cr open charges and ₹85.95 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at D-3 1St Floor, Daginawala Mansion S. B. Rd Mahim - West, Mumbai, Maharashtra, 400016.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239MH2006PLC165473

  • Registration Number

    165473

  • Incorporation Date

    10 November 2006

  • Authorized Capital

    ₹2.50 M

  • Paid-Up Capital

    ₹0.50 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 2.50 M
  • Paid Up Capital ₹ 0.50 M
  • Company Age 19 Year, 3 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 48.38 Cr
  • Satisfied Charges ₹ 85.95 Cr
  • Revenue Growth **** -11.62%
  • Profit Growth **** -17.22%
  • Ebitda **** -4.31%
  • Net Worth 20.80%
  • Total Assets **** 5.52%
Company report

Thinq Pharma-Cro Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Thinq Pharma-Cro Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Thinq Pharma-Cro Limited?
Current Directors
Name Designation Appointment Date Status
Chandrashekhar Shankar Nadkarni Managing Director 10 Nov 2006 Current
Ravindra Ramakant Gulgule Director 15 Sep 2011 Current
Rohit Ramakant Gulgule Director 10 Nov 2006 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 30 Sep 2011 Past
Pramod Abcsdd Director 18 May 2024 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Thinq Pharma-Cro.

Thinq Pharma-Cro Limited, for the financial year ended 2024, experienced significant reduction in revenue, with a 11.62% decrease. The company also saw a substantial fall in profitability, with a 17.22% decrease in profit. The company's net worth Soared by an impressive increase of 20.8%.

Thinq Pharma-Cro revenue growth over time
Thinq Pharma-Cro profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -11.62%
*******
*******
*******
*******
Revenue from Operations
*******
 -9.61%
*******
*******
*******
*******
Total Assets
*******
 5.52%
*******
*******
*******
*******
Profit or Loss
*******
 -17.22%
*******
*******
*******
*******
Net Worth
*******
 20.80%
*******
*******
*******
*******
EBITDA
*******
 -4.31%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Thinq Pharma-Cro?

In 2024, Thinq Pharma-Cro had a promoter holding of 96.00% and a public holding of 4.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹483,821,000.00

Satisfied Charges

₹859,500,000.00

Charges Breakdown by Lending Institutions
  • Standard Chartered Bank : 20.50 Cr
  • The Hongkong And Shanghai Banking Corporation Limited : 20.00 Cr
  • Others : 7.88 Cr
Latest Charge Details
Date Lender Amount Status
31 Oct 2025 Others ₹1.44 Cr Open
30 Oct 2025 Standard Chartered Bank ₹8.50 Cr Open
17 Jun 2025 Standard Chartered Bank ₹12.00 Cr Open
30 Jan 2025 Others ₹7.42 M Open
08 Feb 2024 Others ₹5.70 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Thinq Pharma-Cro?

Thinq Pharma-Cro has a workforce of 148 employees as of Nov 07, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Thinq Pharma-Cro, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Thinq Pharma-Cro's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Thinq Pharma-Cro
Recent Activity within the Organization
  • Charges

    The activity A charge with Others amounted to Rs. 14.40 M with Charge ID 101203004 was registered on 31 Oct 2025. was completed.

  • Charges

    A charge with Standard Chartered Bank amounted to Rs. 85.00 M with Charge ID 101182815 was registered on 30 Oct 2025. was recorded as a recent event.

  • Annual General Meeting

    Progress on Thinq Pharma-Cro Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Charges

    Progress on A charge registered on 02 Jan 2018 via Charge ID 100183710 with Hdfc Bank Limited was fully satisfied on 19 Jul 2025. was documented.

  • Charges

    Progress on A charge registered on 09 Nov 2017 via Charge ID 100136569 with Hdfc Bank Limited was fully satisfied on 19 Jul 2025. was documented.

  • Charges

    Progress on A charge with Standard Chartered Bank amounted to Rs. 120.00 M with Charge ID 101125446 was registered on 17 Jun 2025. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Thinq Pharma-Cro Limited?

The CIN of Thinq Pharma-Cro Limited is U24239MH2006PLC165473.

Where is Thinq Pharma-Cro Limited headquartered?

Thinq Pharma-Cro Limited is headquartered at D-3 1St Floor, Daginawala Mansion S. B. Rd Mahim - West, Mumbai, Maharashtra, 400016.

When was Thinq Pharma-Cro Limited incorporated?

Thinq Pharma-Cro Limited was incorporated on 10 November 2006.

Who are the current directors of Thinq Pharma-Cro Limited?

The current directors of Thinq Pharma-Cro Limited are

What is the primary industry of Thinq Pharma-Cro Limited?

The primary industry of Thinq Pharma-Cro Limited is Manufacturing.

Is Thinq Pharma-Cro Limited a listed company?

Thinq Pharma-Cro Limited is unlisted.

What is the capital structure of Thinq Pharma-Cro Limited?

The authorized capital of Thinq Pharma-Cro Limited is ₹2.50 M, and the paid-up capital is ₹0.50 M.

What is the compliance status of Thinq Pharma-Cro Limited?

The compliance status of Thinq Pharma-Cro Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available